• Monday, Nov 29, 2021
  • Last Update : 05:03 pm

Serum Institute: Covishield vaccine to cost Rs400 per dose for states, Rs600 for private hospitals

  • Published at 10:08 pm April 21st, 2021
Covishield
File photo: A woman reacts as she receives a dose of Covishield Covid-19 vaccine, manufactured by Serum Institute of India, at an auditorium that has been converted into a temporary vaccination centre in Ahmedabad, India, March 24, 2021 Reuters

‘It will still be more affordable than foreign-made ones,’ says the world's largest vaccine manufacturer

The Serum Institute of India on Wednesday announced that its Covid-19 vaccine Covishield will be sold at Rs400 a shot to state governments and Rs600 to private hospitals.

“Considering the global vaccine prices, we are ensuring that our vaccines are affordable in comparison to any other vaccines in the world,” Adar Poonawalla, the chief executive officer of the Serum Institute, said in a statement.

Poonawalla told CNBC-TV18 that the company will sell Covishield doses to Centre at Rs400 per dose once the current purchase order ends. Earlier, the Centre used to get it at Rs150 each, making it the cheapest available option if one gets a shot from a government hospital.

The Pune-based Serum Institute said its vaccines will still be more affordable than foreign-made ones, which cost anywhere from Rs750 to Rs1,500 a shot. The company added that supplying the vaccine independently to corporates would be challenging. It urged companies and individuals to get the shots through states and private hospitals.

Poonawalla said his firm has borrowed money from banks to begin the ramp up of vaccine production. 

“The Rs3,000 crore amount we keep seeing in the media has been sanctioned,” he told NDTV. “We believe it will come to us very soon. We have not waited but borrowed from the banks to get on with the ramp-up, with the assumption that this funding from the government will reach us very soon … this week.”

The Centre has reportedly announced Rs4,500 crore to ramp up Covishield and Covaxin production.

The Serum Institute chief said there was no clarity on the export of vaccines, adding: “We also right now feel that we should not look at exports for two months during these [surge in Covid-19] cases. Maybe in June-July, we could start looking at small exports starting again. Right now, we are going to prioritize the needs of the nation first.”

He also said that the United States’ ban on export of raw materials for coronavirus vaccines will not affect Covishield prices but may “affect the stockpiling of Covovax [a protein-based vaccine of the Serum Institute]”.

Senior Congress leader Jairam Ramesh criticized the Narendra Modi government after the Serum Institute announced the vaccine cost. Assuming that the Centre will get the dose for Rs150 and states at Rs400, he said it was not cooperative federalism.

“This will bleed dry the already reeling state finances,” Ramesh tweeted. “Atrocious. We demand one nation, one price for Centre and state governments.”

Amid a massive surge in infections, the government has allowed vaccination of all persons above the age of 18 from May 1. Under the third phase of the inoculation drive, vaccine manufacturers can sell half of their vaccines to state governments and the private hospitals. The Centre said it will provide vaccines free of cost for only the first 300 million vulnerable persons. After that, vaccines will not be subsidized as they are being at present.

The Centre had asked manufacturers to declare prices for 50% supply that would be available to state governments and in the open market before May 1. Bharat Biotech has yet to announce the price for Covaxin.

67
Facebook 64
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail